Visioneering Technologies (ASX:VTI) executive director & CEO Stephen Snowdy speaks to Proactive Investors about the US-based medical device company's revolutionary Natural VUE multifocal contact lenses for children with myopia and adults with presbyopia.
The vertically integrated company has recently grown its sales team in the US, and now has a large accounts base to leverage increased revenues from. Earlier this year, Visioneering Technologies obtained approvals to market its existing products in Europe, and Australia and New Zealand. Those international launches will happen this year, whilst new product releases are slated for 2019.
